IRIS

Mohanty, S., Casella, M., Compagnucci, P., Torlapati, P.g., La Fazia, V.m., Gianni, C., et al. (2024). Oral anticoagulation and Factor VIII replacement therapy in patients with hemophilia undergoing pulsed-field or radiofrequency catheter ablation for atrial fibrillation. CIRCULATION. ARRHYTHMIA AND ELECTROPHYSIOLOGY, 17(10), 1-3 [10.1161/circep.124.012921].

Oral anticoagulation and Factor VIII replacement therapy in patients with hemophilia undergoing pulsed-field or radiofrequency catheter ablation for atrial fibrillation

La Fazia, Vincenzo Mirco;Natale, Andrea
2024-10-01
ott-2024
Pubblicato
Rilevanza internazionale
Lettera
Esperti anonimi
Settore MEDS-13/C - Chirurgia cardiaca
English
atrial fibrillation
hemophilia
interquartile range
life expectancy
oral anticoagulation
pulsed-field ablation
Mohanty, S., Casella, M., Compagnucci, P., Torlapati, P.g., La Fazia, V.m., Gianni, C., et al. (2024). Oral anticoagulation and Factor VIII replacement therapy in patients with hemophilia undergoing pulsed-field or radiofrequency catheter ablation for atrial fibrillation. CIRCULATION. ARRHYTHMIA AND ELECTROPHYSIOLOGY, 17(10), 1-3 [10.1161/circep.124.012921].
Mohanty, S; Casella, M; Compagnucci, P; Torlapati, Pg; La Fazia, Vm; Gianni, C; Macdonald, B; Mayedo, Aq; Della Rocca, Dg; Allison, J; Bassiouny, M; G...espandi
Articolo su rivista
01 - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/417339
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact